Clarification sought from Sun Pharmaceutical Industries

16 Feb 2017 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries on February 16, 2017, with reference to news appeared in CNBC TV 18 dated February 16, 2017 ‘UK Regulator approves Sun Pharma Generic drug of Tobramycin.’

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1794.30 -12.60 (-0.70%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×